This study included 12 week-old Wistar albino male rats that were bred in-house at the animal facility at the Department of Pharmacology, School of Medicine in Zagreb, Croatia
However, consult your healthcare provider before starting a biweekly dosing schedule to ensure a safe transition and avoid fluctuations in blood sugar levels
Ongoing Support: Monitoring and adjustments throughout your program
By doing so, physicians can tailor the treatment regimen to patients lifestyle and preferences
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes and obesity, have evolved into multi-organ potential therapeutics due to their pleiotropic effects beyond glycemic control
However, the relationship is the opposite for weight loss, with more weight loss observed with long-acting GLP-1RAs despite the lesser effect of these drugs on gastric emptying